Search

Displaying results 9641 - 9650 of 10000 in total
  1. Drug

    Povafonidine

    go.drugbank.com/drugs/DB21470
    Experimental

    The usage of the INN stem '-nidine' in the name indicates that Povafonidine is a a2 adrenoreceptor agonist. Povafonidine has a monoisotopic molecular weight of 215.12 Da.

  2. Drug

    Xininurad

    go.drugbank.com/drugs/DB21564
    Experimental

    The usage of the INN stem '-inurad' in the name indicates that Xininurad is a urate transporter inhibitor. Xininurad has a monoisotopic molecular weight of 440.91 Da.

  3. Drug

    Ansornitinib

    go.drugbank.com/drugs/DB21577
    Experimental

    The usage of the INN stem '-tinib' in the name indicates that Ansornitinib is a tyrosine kinase inhibitor. Ansornitinib has a monoisotopic molecular weight of 540.25 Da.

  4. Drug

    Garsorasib

    go.drugbank.com/drugs/DB21581
    Investigational

    The usage of the INN stem '-rasib' in the name indicates that Garsorasib is a Ras protein inhibitor. Garsorasib has a monoisotopic molecular weight of 598.26 Da.

  5. Drug

    Gumelutamide

    go.drugbank.com/drugs/DB21615
    Experimental

    The usage of the INN stem '-lutamide' in the name indicates that Gumelutamide is a non-steroid antiandrogen. Gumelutamide has a monoisotopic molecular weight of 420.15 Da.

  6. Drug

    Frevecitinib

    go.drugbank.com/drugs/DB21681
    Investigational

    The usage of the INN stem '-citinib' in the name indicates that Frevecitinib is a Janus kinase inhibitor. Frevecitinib has a monoisotopic molecular weight of 415.18 Da.

  7. Drug

    Odentegravir

    go.drugbank.com/drugs/DB21708
    Experimental

    The usage of the INN stem '-tegravir' in the name indicates that Odentegravir is a HIV integrase inhibitor. Odentegravir has a monoisotopic molecular weight of 421.12 Da.

  8. Drug

    V-SARS

    go.drugbank.com/drugs/DB15812
    Investigational

    Immunitor Inc., the sponsor, is currently testing this oral vaccine for immunogenicity in 20 healthy volunteers in a Phase 1 clinical trial (NCT04380532).

  9. Drug

    IMMU-114

    go.drugbank.com/drugs/DB18458
    Investigational

    IMMU-114 is antibody-drug conjugate consisting of humanized anti-HLA-DR IgG4 monoclonal antibody specific for alpha-chain linked to SN-38 via a CL2A linker.

  10. Drug

    ALT-P1

    go.drugbank.com/drugs/DB18485
    Investigational

    ALT-P1 is a long-acting recombinant human growth hormone fused to an alpha1-antitrypsin variant. It is under investigation for the treatment of growth hormone deficiency.